AAD  Vol.6 No.1 , March 2017
Insufficiency of Cellular Energy (ICE) May Precede Neurodegeneration in Alzheimer’s Disease and Be Treatable via the Alternative Cellular Energy (ACE) Pathway
Abstract: The term neurodegeneration emphasizes the destruction of neuronal cells as the primary explanation of many major neurological illnesses, including Alzheimer’s disease. Specialized functioning of cells requires more cellular energy than is needed for basic cell survival. Cells can acquire energy both from the metabolism of food and from the alternative cellular energy (ACE) pathway. The ACE pathway is an added dynamic (kinetic) quality of the body’s fluids occurring from the absorption of an external force termed KELEA (Kinetic Energy Limiting Electrostatic Attraction). KELEA is attracted to separated electrical charges and is seemingly partially released as the charges become more closely linked. As suggested elsewhere, the fluctuating electrical activity in the brain may attract KELEA from the environment and, thereby, contribute to the body’s ACE pathway. Certain illnesses affecting the brain may impede this proposed antenna function of the brain, leading to a systemic insufficiency of cellular energy (ICE). Furthermore, individual neurons may derive some of the energy for their own activities from the repetitive depolarization of the cell. This may explain why hyper-excitability of neurons can occur in response to cell damage. This adaptive mechanism is unlikely to be sustainable, however, especially if there is a continuing need to synthesize neurotransmitters and membrane ion channels. The energy deficient neurons would then become quiescent and, although remaining viable, would not perform their intended specialized functions. Actual cell death would not necessarily occur till much later in the disease process. The distinction between quiescent and degenerated cells is important since the ACE pathway can be enhanced by several means, including the regular consumption of KELEA activated water. This, in turn, may improve the proposed antenna function of individual neurons, leading to a sustained restoration of specialized function via the ACE pathway. This paper explores this novel concept and provides a rationale for clinical testing of KELEA activated water in patients with neurological and psychiatric illnesses, including Alzheimer’s disease.
Cite this paper: Martin, W. (2017) Insufficiency of Cellular Energy (ICE) May Precede Neurodegeneration in Alzheimer’s Disease and Be Treatable via the Alternative Cellular Energy (ACE) Pathway. Advances in Alzheimer's Disease, 6, 1-12. doi: 10.4236/aad.2017.61001.

[1]   Martin, W.J. (2003) Stealth Virus Culture Pigments: A Potential Source of Cellular Energy. Experimental and Molecular Pathology, 74, 210-223.

[2]   Martin, W.J. (1994) Stealth Viruses as Neuropathogens. College of American Pathologist’s Publication, CAP Today, 8, 67-70.

[3]   Martin, W.J., Zeng, L.C., Ahmed, K. and Roy, M. (1994) Cytomegalovirus Related Sequences in an Atypical Cytopathic Virus Repeatedly Isolated from a Patient with the Chronic Fatigue Syndrome. American Journal Pathology, 145, 440-451.

[4]   Martin, W.J. (2014) Stealth Adaptation of Viruses: Review and Updated Molecular Analysis on a Stealth Adapted African Green Monkey Simian Cytomegalovirus (SCMV). Journal of Human Virology and Retrovirology, 1, Article ID: 00020.

[5]   Martin, W.J. (2014) The Alternative Cellular Energy (ACE) Pathway in the Repair of the Cytopathic Effect (CPE) Caused by Stealth Adapted Viruses. In Vitro and in Vivo Evidence Supporting a New Therapeutic Paradigm. In Stealth Adapted Viruses; Alternative Cellular Energy (ACE) & KELEA Activated Water. Author House Bloomington, IN, 31-70.

[6]   Martin, W.J. (2015) Therapeutic Potential of KELEA Activated Water. International Journal of Complementary and Alternative Medicine, 1, Article ID: 00001.

[7]   Martin, W.J. (2015) Alternative Cellular Energy Pathway Therapy Using KELEA Activated Water. International Journal of Complementary and Alternative Medicine, 2, Article ID: 00051.

[8]   Martin, W.J. (2015) KELEA Activation of Water and Other Fluids for Health, Agriculture and Industry. Journal of Water Resource and Protection, 7, 1331-1344.

[9]   Martin, W.J. (2015) KELEA: A Natural Energy That Seemingly Reduces Intermolecular Hydrogen Bonding in Water and Other Liquids. Open Journal of Biophysics, 5, 69-79.

[10]   Martin, W.J. (2016) KELEA (Kinetic Energy Limiting Electrostatic Attraction) Offers an Alternative Explanation to Existing Concepts Regarding Wave-Particle Duality, Cold Fusion and Superconductivity. Journal of Modern Physics, 7, 1995-2007.

[11]   Martin, W.J. (2015) Preparing and Using KELEA Activated Water to Enhance the Alternative Cellular Energy (ACE) Pathway in the Therapy of Multiple Illnesses. International Journal Complementary & Alternative Medicine, 3, Article ID: 00059.

[12]   Martin, W.J. (2015) Interacting Light Paths Attract KELEA (Kinetic Energy Limiting Electrostatic Attraction) and Can Lead to the Activation of Water. Open Journal of Biophysics, 5, 115-121.

[13]   Martin, W.J. (2015) Interactive Electric Fields Attract KELEA (Kinetic Energy Limiting Electrostatic Attraction) and Can Lead to the Activation of Water. International Journal Complementary Alternative Medicine, 1, Article ID: 00034.

[14]   Pessarakli, M. (2016) Handbook of Photosynthesis. 3rd Edition, CRC Press, Boca Raton, 846.

[15]   Smeitink, J.A.M. (2007) Oxidative Phosphorylation in Health and Disease. Springer Publishing, New York, 205.

[16]   Barlow, J.S. (1993) The Electroencephalogram, Its Patterns and Origins. MIT Press, Cambridge, 456.

[17]   Fox, M.D. and Raichle, M.E. (2007) Spontaneous Fluctuations in Brain Activity Observed with Functional Magnetic Resonance Imaging. Nature Reviews Neuroscience, 8, 700-711.

[18]   Llinás, R.R., Grace, A.A. and Yarom, Y. (1991) In Vitro Neurons in Mammalian Cortical Layer 4 Exhibit Intrinsic Oscillatory Activity in the 10- to 50-Hz Frequency Range. Proceedings of the National Academy of Sciences of the United States of America, 88, 897-901.

[19]   Moore, A.R., Zhou, W.-L., Jakovcevski, I., Zecevic, N. and Antic, S.D. (2011) Spontaneous Electrical Activity in the Human Fetal Cortex in Vitro. Journal of Neuroscience, 31, 2391-2398.

[20]   Martin, W.J. (2014) KELEA Activated Water—Enhancing the Alternative Cellular Energy (ACE) Pathway. In: Martin, W.J., Ed., Stealth Adapted Viruses; Alternative Cellular Energy (ACE) & KELEA Activated Water, AuthorHouse, Bloomington, 115-144.

[21]   Martin, W.J. (2015) Is the Brain an Activator of the Alternative Cellular Energy (ACE) Pathway? International Journal Complementary Alternative Medicine, 1, Article ID: 00002.

[22]   Martin, W.J. (2016) The Alternative Cellular Energy (ACE) Pathway as a Primary Non-Immunological Defense Mechanism Against Infectious Diseases. Juniper Online Journal of Immuno Virology, 1, Article ID: 555563.

[23]   Martin, W.J. (2016) Cancer as an Insufficiency of Cellular Energy (ICE), Therapeutic Approaches Based on Enhancing the Alternative Cellular Energy (ACE) Pathway. International Journal Complementary Alternative Medicine, 3, Article ID: 00074.

[24]   Kaplan, J.H. (2002) Biochemistry of Na, K-ATPase. Annual Review of Biochemistry, 71, 511-535.

[25]   Astrup, J., Sørensen, P.M. and Sørensen, H.R. (1981) Oxygen and Glucose Consumption Related to Na+-K+ Transport in Canine Brain. Stroke, 12, 726-730.

[26]   Martonosi, A.N. (2012) Membranes and Transport. Springer Publishing, New York, 722.

[27]   Wang, R., Tsuda, I. and Zhang, Z. (2015) A New Work Mechanism on Neuronal Activity. International Journal of Neural Systems, 25, Article ID: 1450037.

[28]   Ames, A. (2000) CNS Energy Metabolism as Related to Function. Brain Research Reviews, 34, 42-68.

[29]   Attwell, D. and Laughlin, S.B. (2001) An Energy Budget for Signaling in the Grey Matter of the Brain. Journal of Cerebral Blood Flow & Metabolism, 21, 1133-1145.

[30]   Niven, J.E. (2016) Neuronal Energy Consumption, Biophysics, Efficiency and Evolution. Current Opinion in Neurobiology, 41,129-135.

[31]   Lirk, P., Poroli, M., Rigaud, M., Fuchs, A., Fillip, P., Huang, C.-Y., et al. (2008) Modulators of Calcium Influx Regulate Membrane Excitability in Rat Dorsal Root Ganglion Neurons. Anesthesia Analgesia, 107, 673-685.

[32]   Ednie, A.R. and Bennett, E.S. (2012) Modulation of Voltage-Gated Ion Channels by Sialylation. Comprehensive Physiology, 2, 1269-301.

[33]   Hollingworth, P., Harold, D., Jones, L., Owen, M.J. and Williams, J. (2011) Alzheimer’s Disease Genetics, Current Knowledge and Future Challenges. International Journal Geriatric Psychiatry, 26, 793-802.

[34]   Lehmann, S. and Teunissen, C.E. (2016) Biomarkers of Alzheimer’s Disease, the Present and the Future. Frontiers Media, Lausanne, 213.

[35]   Drachman, D.A. (2014) The Amyloid Hypothesis, Time to Move on, Amyloid Is the Downstream Result, Not Cause, of Alzheimer’s Disease. Alzheimer’s Dement, 10, 372-380.

[36]   Herrup, K. (2015) The Case for Rejecting the Amyloid Cascade Hypothesis. Nature Neuroscience, 18, 794-799.

[37]   Martin, W.J. (2015) Stealth Adapted Viruses—Possible Drivers of Major Neuropsychiatric Illnesses Including Alzheimer’s Disease. Journal of Neurology & Stroke, 2, Article ID: 00057.

[38]   Busche, M.A. and Konnerth, A. (2015) Neuronal Hyperactivity—A Key Defect in Alzheimer’s Disease? Bioessays, 37, 624-632.

[39]   Stargardt, A., Swaab, D.F. and Bossers, K. (2015) The Storm before the Quiet, Neuronal Hyperactivity and AB in the Presymptomatic Stages of Alzheimer’s Disease. Neurobiology of Aging, 36, 1-11.

[40]   Dickerson, B.C., Salat, D.H., Greve, D.N., Chua, E.F., Rand-Giovannetti, E., Rentz, D.M., et al. (2005) Increased Hippocampal Activation in Mild Cognitive Impairment Compared to Normal Aging and AD. Neurology, 65, 404-411.

[41]   Bakker, A., Krauss, G.L., Albert, M.S., Speck, C.L., Jones, L.R., Stark, C.E., et al. (2012) Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment. Neuron, 74, 467-474.

[42]   Albers, M.W., Gilmore, G.C., Kaye, J., Murphy, C., Wingfield, A., Bennett, D.A., et al. (2015) At the Interface of Sensory and Motor Dysfunctions and Alzheimer’s Disease. Alzheimer’s & Dementia, 11, 70-98.

[43]   Lyketsos, C.G., Carrillo, M.C., Ryan, J.M., Khachaturian, A.S., Trzepacz, P., Amatniek, J., et al. (2011) Neuropsychiatric Symptoms in Alzheimer’s Disease. Alzheimer’s & Dementia, 7, 532-539.

[44]   Zhao, Q.-F., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., et al. (2016) The Prevalence of Neuropsychiatric Symptoms in Alzheimer’s Disease, Systematic Review and Meta-Analysis. Journal of Affective Disorders, 190, 264-271.

[45]   Irizarry, M.C., Jin, S., He, F., Emond, J.A., Raman, R., Thomas, R.G., et al. (2012) Incidence of New-Onset Seizures in Mild to Moderate Alzheimer Disease. Archives of Neurology, 69, 368-372.

[46]   Bom, H.A. (2014) Seizures in Alzheimer’s Disease. Neuroscience, 286, 251-263.

[47]   Vossel, K.A., Beagle, A.J., Rabinovici, G.D., Shu, H., Lee, S.E., Naasan, G., et al. (2013) Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease. JAMA Neurology, 70, 1158-1166.

[48]   Gates, G.A., Anderson, M.L., Feeney, M.P., McCurry, S.M. and Larson, E.B. (2008) Central Auditory Dysfunction in Older Persons with Memory Impairment or Alzheimer Dementia. Archives of Otolaryngology—Head and Neck Surgery, 134, 771-777.

[49]   Murphy, C., Gilmore, M.M., Seery, C.S., Salmon, D.P. and Lasker, B.R. (1990) Olfactory Thresholds are Associated with Degree of Dementia in Alzheimer’s Disease. Neurobiology of Aging, 11, 465-469.

[50]   Pache, M., Smeets, C.H., Gasio, P.F., Savaskan, E., Flammer, J., Wirz-Justice, A., et al. (2003) Colour Vision Deficiencies in Alzheimer’s Disease. Age Ageing, 32, 422-426.

[51]   Rizzo, M., Anderson, S.W., Dawson, J. and Nawrot, M. (2000) Vision and Cognition in Alzheimer’s Disease. Neuropsychologia, 38, 1157-1169.

[52]   Femminella, G.D., Rengo, G., Komici, K., Iacotucci, P., Petraglia, L., Pagano, G., et al. (2014) Autonomic Dysfunction in Alzheimer’s Disease, Tools for Assessment and Review of the Literature. Journal of Alzheimer’s Disease, 42, 369-377.

[53]   Lange, K.W., Katharina, M., Lange, K.M., Makulska-Gertruda, E., Nakamura, Y., Reissmann, A., et al. (2016) Ketogenic Diets and Alzheimer’s Disease. Food Science and Human Wellness, in Press.

[54]   Frisardi, V., Panza, F., Seripa, D., Imbimbo, B.P., Vendemiale, G., Pilotto, A., et al. (2010) Nutraceutical Properties of Mediterranean Diet and Cognitive Decline, Possible Underlying Mechanisms. Journal of Alzheimer’s Disease, 22, 715-740.

[55]   Solfrizzi, V., Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B.P., et al. (2011) Diet and Alzheimer’s Disease Risk Factors or Prevention, the Current Evidence. Expert Review of Neurotherapeutics, 11, 677-708.

[56]   Hügel, H.M. (2015) Brain Food for Alzheimer-Free Ageing, Focus on Herbal Medicines. Advances in Experimental Medicine and Biology, 863, 95-116.

[57]   Cernacchi, T., Bertoldin, T., Farina, C., Flori, M.G. and Crepaldi, G. (1993) Cognitive Decline in the Elderly, a Double-Blind, Placebo-Controlled Multicenter Study on the Efficacy of Phosphatidylserine Administration. Aging, 5, 123-133.

[58]   Nicolson, G. (2016) Clinical Uses of Membrane Lipid Replacement Supplements in Restoring Membrane Function and Reducing Fatigue in Chronic Diseases and Cancer. Discoveries, 4, e54.

[59]   Obulesu, M. and Rao, D.M. (2011) Effect of Plant Extracts on Alzheimer’s Disease, an Insight into Therapeutic Avenues. Journal of Neurosciences in Rural Practice, 2, 56-61.

[60]   Morris, M.C., Evans, D.A., Bienias, J.L., Scherr, P.A., Tangney, C.C., Hebert, L.E., et al. (2004) Dietary Niacin and the Risk of Incident Alzheimer’s Disease and of Cognitive Decline. Journal of Neurology, Neurosurgery & Psychiatry, 75, 1093-1099.

[61]   Dubner, L., Wang, J., Ho, L., Ward, L. and Pasinetti, G.M. (2015) Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer’s Disease, Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging. Journal of Alzheimer’s Disease, 48, 879-889.

[62]   Kamphuis, P.J. and Scheltens, P. (2010) Can Nutrients Prevent or Delay Onset of Alzheimer’s Disease? Journal of Alzheimer’s Disease, 20, 765-775.

[63]   Martin, W.J. and Laurent, D. (2015) Homeopathy as a Misnomer for Activation of the Alternative Cellular Energy Pathway, Evidence for the Therapeutic Benefits of Enercel in a Diverse Range of Clinical Illnesses. International Journal Complementary Alternative Medicine, 2, Article ID: 00045.

[64]   Dubrov, V., Dubrova, T., Christner, D., Laurent, D. and Martin, W.J. (2015) Alternative Cellular Energy Based Therapy Using Enercel in Advanced AIDS Patients Co-Infected with Tuberculosis and Treated in Chernigov, Ukraine. Journal Human Virology Retrovirology, 2, Article ID: 00061.

[65]   Martin, W.J. and Stoneburner, J. (2005) Symptomatic Relief of Herpetic Skin Lesions Utilizing an Energy Based Approach to Healing. Experimental Molecular Pathology, 78, 131-134.

[66]   Martin, W.J. (2014) Alternative Cellular Energy (ACE) Pathway Activation as Natural Therapy for Autism. In: Martin, W.J., Ed., Stealth Adapted Viruses; Alternative Cellular Energy (ACE) & KELEA Activated Water, AuthorHouse, Bloomington, 87-102.

[67]   Martin, W.J. (2016) Insufficiency of Cellular Energy (ICE) in Neurons, From Electrical Hyperactivity to Quiescence. International Journal Complementary Alternative Medicine, 4, Article ID: 00118.